Page last updated: 2024-08-23

idarubicin and Chemotherapy-Induced Febrile Neutropenia

idarubicin has been researched along with Chemotherapy-Induced Febrile Neutropenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Barbon Gauro, J; Heng, MS; Thomas, J; Yaxley, A1
Kungwankiattichai, S; Owattanapanich, N; Owattanapanich, W; Ruchutrakool, T; Ungprasert, P1

Reviews

1 review(s) available for idarubicin and Chemotherapy-Induced Febrile Neutropenia

ArticleYear
Efficacy and Toxicity of Idarubicin Versus High-dose Daunorubicin for Induction Chemotherapy in Adult Acute Myeloid Leukemia: A Systematic Review and Meta-analysis.
    Clinical lymphoma, myeloma & leukemia, 2018, Volume: 18, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy-Induced Febrile Neutropenia; Daunorubicin; Female; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Odds Ratio; Remission Induction; Treatment Outcome; Young Adult

2018

Other Studies

1 other study(ies) available for idarubicin and Chemotherapy-Induced Febrile Neutropenia

ArticleYear
Does a neutropenic diet reduce adverse outcomes in patients undergoing chemotherapy?
    European journal of cancer care, 2020, Volume: 29, Issue:1

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Infections; Carmustine; Chemotherapy-Induced Febrile Neutropenia; Cytarabine; Diet Therapy; Enterocolitis, Neutropenic; Female; Hematologic Neoplasms; Humans; Idarubicin; Male; Melphalan; Middle Aged; Neutropenia; Podophyllotoxin; Retrospective Studies; South Australia

2020